Could a common hormone be better for blood pressure during lung surgery?

NCT ID NCT07614438

Not yet recruiting Disease control Sponsor: Fondation Hôpital Saint-Joseph Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two drugs, vasopressin and norepinephrine, given during and after surgery to remove chronic blood clots from the lungs. The goal is to see which drug better controls blood pressure in the lungs without harming the rest of the body. About 90 adults scheduled for this surgery will take part, and their lung artery pressure will be measured right after the operation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Vasopressin
What this could lead to: If vasopressin works better, it could become the preferred drug to manage blood pressure during and after this lung surgery, potentially improving recovery.
What could go wrong: This is a small, early-phase trial with only 90 participants at one hospital. The drug may not show a clear benefit over the standard treatment, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic thromboembolic pulmonary hypertension pulmonary hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANESTHESIA CHRONIC PULMONARY THROMBOEMBOLISM PULMONARY HYPERTENSION VASOPRESSOR

Contacts and locations

Locations

Hôpital Marie Lannelongue

Le Plessis-Robinson, 92350, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.